Bluebird Bio Inc Asset Turnover Ratio (BLUE), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bluebird Bio Inc   (NASDAQ: BLUE)
 

Bluebird Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Bluebird Bio Inc asset turnover ratio, the ability of Bluebird Bio Inc 's assets to generate revenue in the first quarter 2025, increased sequentially to 0.34 in the first quarter (Mar 31 2025), BLUE's balance sheet remain strong.

Within sector 33 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2025 compared to the preceding quarter from 0 to 2748.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLUE Asset Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Asset Change -32.41 % -31.9 % -11.29 % -1.49 % 3.26 %
Y / Y Revenue Change 108.43 % 391.72 % -14.36 % 133.69 % 680.05 %
Asset Turnover Ratio (TTM) 0.34 0.25 0.14 0.14 0.12
BLUE's Total Ranking # 2748 # 0 # 2726 # 2642 # 2829
Seq. Asset Change 3.53 % 0.36 % -20.42 % -18.25 % 4.31 %
Seq. Revenue Change 0.5 % 262.99 % -34.09 % -13.31 % 137.08 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 34
Healthcare Sector # 413
Overall Market # 2748

Asset Turnover Ratio Statistics
High Average Low
0.24 0.04 -0.06
(Mar 31 2025)   (Sep 30 2022)




BLUE Company Profile • Back to BLUE Efficiency Comparisons • Compare BLUE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Assets at quarter ending Mar 31 2025
Pediatrix Medical Group Inc   0.96 $ 1,976.177  Millions$ 2,054.601  Millions
Evofem Biosciences Inc   0.96 $ 16.605  Millions$ 17.290  Millions
Ensign Group Inc  0.96 $ 4,423.354  Millions$ 4,623.925  Millions
Addus Homecare Corp  0.95 $ 1,211.521  Millions$ 1,272.418  Millions
Acadia Pharmaceuticals Inc   0.95 $ 996.283  Millions$ 1,052.772  Millions
Strata Critical Medical Inc   0.94 $ 251.485  Millions$ 267.625  Millions
Cerus Corporation  0.94 $ 183.674  Millions$ 195.682  Millions
Ufp Technologies Inc   0.94 $ 546.761  Millions$ 583.135  Millions
Elite Pharmaceuticals Inc   0.93 $ 83.087  Millions$ 89.021  Millions
Ardelyx inc   0.93 $ 361.706  Millions$ 389.325  Millions
Orthofix Medical Inc   0.93 $ 804.262  Millions$ 866.577  Millions
Angiodynamics Inc   0.93 $ 281.467  Millions$ 303.596  Millions
National Healthcare Corp  0.93 $ 1,383.903  Millions$ 1,493.914  Millions
Delcath Systems Inc   0.92 $ 52.817  Millions$ 57.376  Millions
Sbc Medical Group Holdings Incorporated  0.91 $ 196.495  Millions$ 216.673  Millions
Avita Medical Inc   0.90 $ 71.661  Millions$ 79.536  Millions
Community Health Systems Inc   0.90 $ 12,653.000  Millions$ 14,065.000  Millions
Apellis Pharmaceuticals Inc   0.89 $ 775.839  Millions$ 874.671  Millions
Bionexus Gene Lab Corp   0.88 $ 9.266  Millions$ 10.512  Millions
Cadre Holdings inc   0.88 $ 558.440  Millions$ 636.563  Millions
National Vision Holdings Inc   0.88 $ 1,791.121  Millions$ 2,046.138  Millions
Ptc Therapeutics inc   0.87 $ 1,772.758  Millions$ 2,029.751  Millions
Embecta Corp   0.87 $ 1,078.100  Millions$ 1,239.575  Millions
Lensar Inc   0.87 $ 57.065  Millions$ 65.670  Millions
Ironwood Pharmaceuticals inc   0.87 $ 317.676  Millions$ 365.815  Millions
Strata Skin Sciences Inc  0.86 $ 32.467  Millions$ 37.551  Millions
Corcept Therapeutics Inc  0.86 $ 685.446  Millions$ 796.455  Millions
Lakeland Industries Inc   0.86 $ 177.648  Millions$ 207.573  Millions
Scientific Industries Inc   0.86 $ 10.636  Millions$ 12.428  Millions
Neuropace Inc   0.85 $ 84.084  Millions$ 98.886  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.